Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
出版年份 2010 全文链接
标题
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 103, Issue 7, Pages 1008-1018
出版商
Springer Nature
发表日期
2010-08-25
DOI
10.1038/sj.bjc.6605839
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
- (2010) J.L. Hao et al. CURRENT CANCER DRUG TARGETS
- CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts
- (2009) E Marangoni et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells
- (2009) Mark G. Slomiany et al. CANCER RESEARCH
- Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer
- (2009) N. R. Dean et al. CLINICAL CANCER RESEARCH
- The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer
- (2009) Céline Pinheiro et al. EUROPEAN JOURNAL OF CANCER
- CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
- (2009) W Schneiderhan et al. GUT
- Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells
- (2009) Claudio Surace et al. MOLECULAR PHARMACEUTICS
- Hyaluronic Acid-Modified DOTAP/DOPE Liposomes for the Targeted Delivery of Anti-Telomerase siRNA to CD44-Expressing Lung Cancer Cells
- (2009) Sebastian Taetz et al. OLIGONUCLEOTIDES
- The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
- (2008) Michele C. Madigan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis
- (2008) Juan Su et al. CANCER LETTERS
- Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading
- (2008) M. J. Albers et al. CANCER RESEARCH
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
- (2008) Bryan P. Toole et al. DRUG RESISTANCE UPDATES
- Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma
- (2008) Céline Pinheiro et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- An insight on hyaluronic acid in drug targeting and drug delivery
- (2008) Awesh K. Yadav et al. JOURNAL OF DRUG TARGETING
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor
- (2008) Virginia M. Platt et al. MOLECULAR PHARMACEUTICS
- CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer
- (2008) Wei-de Zhong et al. ONCOLOGY
- Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
- (2008) Céline Pinheiro et al. VIRCHOWS ARCHIV
- The Multidrug Transporter P-Glycoprotein: A Mediator of Melanoma Invasion?
- (2007) Marisa Colone et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation